Clinical trial
Long Term Follow-up of Subjects Who Received GRNOPC1
NCT05919563 is registered in ClinicalTrials.gov with Lineage Cell Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Follow-up of Subjects Who Received GRNOPC1
- Lead sponsor
- Lineage Cell Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 6, 2011
- Completion date
- December 12, 2026
- Enrollment
- 5 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.